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The European Renal Genome Project
An Integrated Approach Towards Understanding the Genetics
of Kidney Development and Disease
ABSTRACT
Rapid progress in genome research creates a wealth of information on the functional
annotation of mammalian genome sequences. However, as we accumulate large amounts
of scientific information we are facing problems of how to integrate and relate the data
produced by various genomic approaches. Here, we propose the novel concept of an
organ atlas where diverse data from expression maps to histological findings to mutant
phenotypes can be queried, compared and visualized in the context of a three-dimensional
reconstruction of the organ. We will seek proof of concept for the organ atlas by eluci-
dating genetic pathways involved in development and pathophysiology of the kidney.
Such a kidney atlas may provide a paradigm for a new systems-biology approach in
functional genome research aimed at understanding the genetic bases of organ develop-
ment, physiology and disease.
INTRODUCTION
Elucidation of the human and other vertebrate genomes heralds a new era in biomedical
research that offers unprecedented opportunities to understand disease processes and to
identify strategies to improve health. Deciphering the three billion base pairs of the mam-
malian genome provides us with a blueprint of the genetic map that defines the activities
of cells and tissues, organs and entire organisms. However, before being able to fully
exploit the wealth of information presented in genomes, we need to assign functions to
individual genes and we need to understand their interaction in intricate complex networks
that control all biological processes.
According to current estimates, mammalian genomes encode 20,000 to 30,000 genes
(www.ensemble.org). Taking into account that, by differential splicing or RNA editing,
multiple transcripts may originate from a single gene, mammalian tissues are expected to
express a minimum of 40,000 different proteins.1 Based on previous analysis of the human
genome,2 approximately one third of all mammalian genes can be grouped into known
functional categories such as transcription factors, receptors and ligands, or structural
proteins. Another third exhibits sequence similarity to known genes, providing at least an
educated guess about their possible functions. This leaves us with no less than 30% of the
mammalian genome (or 13.000 genes) that needs de novo functional annotation—a
tremendous challenge in current genome research.
Application of transgenic technologies in model organisms has arguably been the single
most successful approach to uncover the previously unknown function of new genes. In a
process known as reverse genetics, we can manipulate the expression of individual genes
and study the (patho)physiological consequences of altered gene expression in cells, tissues
or intact organisms. Aided by major technological advances in molecular biology, we can
today easily inactivate the expression of genes in living organisms using, for example, gene
targeting or silencing by small interference RNAs and antisense oligonucleotide
knock-down. We can ectopically express or overexpress genes, using pronuclear injection
of gene constructs or somatic cell gene transfer, and we can evaluate the effects of such
manipulations using a variety of sophisticated methods including gene expression profiling
by micro arrays, in vivo imaging, and high-throughput in situ hybridizations. With respect
to kidney development and disease, transgenic approaches, for example, have elucidated
the crucial role of Wt1 and Wnt4 as key genes in nephrogenesis3-6 and helped to uncover
the importance of chloride channels ClC-K and ClC-5 in ion handling of the kidney and
in the occurrence of renal salt wasting syndromes in humans.7-13
UNDERSTANDING THE COMPLEXITY OF GENETIC SYSTEMS
While the remarkable success of reverse genetics is well appreci-
ated, we have to keep in mind that studying one gene at a time may
pose conceptual problems when trying to understand the complexity
of biological systems. Much like the famous “six blind men from
Indostan”, in the poem by John Godfrey Saxe (1816–1887), who
fail to accurately describe the appearance of an elephant because
each of them is fooled by the selective impression of touching trunk,
tail or ear of the animal, we have to be aware that studying individual
genes or gene pathways inevitably falls short of revealing the complete
picture of a physiological process. For example, while monogenic
approaches in kidney research have uncovered major gene pathways
controlling volume and electrolyte homeostasis,14,15 the majority of
patients with end-stage renal failure are not affected by single gene
mutations in such master genes but rather by a complex interplay of
environmental and genetic risk factors influencing susceptibility to
the most prevalent renal diseases such as hypertension-induced kidney
damage, diabetic nephropathy and glomerulonephritis.
Thus, novel concepts are emerging in which the study of an
organism is viewed as an interacting network of genes, proteins and
biochemical reactions-interactions that are ultimately responsible for
an organism’s form and (mal)functions. In this new discipline,
commonly referred to as Systems Biology, the individual activities
and collective interaction of genes, proteins and other components
in an organism are characterized as an integrated network. For
Systems Biology to work, novel tools from theoretical disciplines
such as bioinformatics and applied mathematics have to be devel-
oped and combined with classical wet-lab experiments of molecular
biology, biochemistry or physiology.
Towards a new systems approach in kidney research, the European
Renal Genome Project (EuReGene) will pursue combining the
effectiveness of monogenic strategies in model organisms with novel
bioinformatics programs to develop an organ atlas that describes the
spatial and temporal relationship of major gene pathways in kidney
development and disease. It will integrate available information
from many sources into the framework of a four-dimensional atlas
where novel functional relationships can be uncovered in an envi-
ronment that is not constrained by current hypotheses.
WHY THE KIDNEY?
A prerequisite for an organ atlas is a target tissue with a well-
defined structure-function relationship. Before outlining the concept
of a kidney atlas in detail, we have to consider why the kidney may
be an appropriate tissue to develop the concept of an organ atlas.
In terms of developmental programs, nephrogenesis recapitulates
major steps in organ formation, including the differentiation of
primordial cells into an array of highly specialized cell types and the
instructive interaction of different germ layers to form a complex
organ structure. Development of the metanephros, the permanent
kidney of mammals, proceeds in three steps, each of which is essential
for the formation of a functional excretory organ.16,17 It encompasses
the induction, growth and branching of the ureter from the
mesonephric or Wolffian duct (Fig. 1A), the initiation of nephroge-
nesis as a result of reciprocal interactions between the ureter and the
metanephric mesenchyme (Fig. 1B), and finally the patterning and
terminal differentiation of the nephron (Fig. 1C–E). The emerging
mature kidney consists of a complex three-dimensional assembly of
more than twenty different cell types capable of executing complex
physiological functions.
As well as representing a paradigm for organogenesis, the kidney
also proves an attractive model for elucidating the complex interaction
of many specialized cell types in a mature organ. This notion is
particularly supported by the fact that its well-defined tissue archi-
tecture is closely aligned with biochemical function (Fig. 2). The
adult human kidney consists of approximately one million nephrons,
functional units that are composed of differentiated structures and
cell types. The glomerulus acts as selective filter that retains the bulk
of plasma proteins but permits passage of water and solutes, which,
for the major part, are subsequently reabsorbed along specialized
nephron segments. Podocytes are specialized cells with interdigitated
foot processes in the glomerulus. They synthesize the slit diaphragm
proteins, nephrin and podocin, which play an essential role in deter-
mining glomerular permeability. Mutations in these genes and injury
to podocytes lead to proteinuria, a hallmark of most glomerular
diseases. Renal vessels, including glomerular capillaries are lined by
endothelial cells. They are key actors in vasculitis, triggered by
immune processes or high blood pressure causing tissue damage and
renal failure. Following passage through the glomerulus, the ultra
filtrate enters the proximal tubule. Here, epithelial cells endocytose
many low molecular weight proteins and potentially toxic drug
metabolites that are freely filtered. The bulk of ion and water reab-
sorption also takes place in this nephron segment whereas finer
adjustments are made in more distal segments such as the distal
convoluted tubules and the collecting ducts. These highly regulated
processes involve transporters that use the energy stored in transmem-
brane ionic gradients, as well as ion-specific channels and ion-motive
ATPases. In addition to the specialized NaCl-reabsorbing function,
which drives fluid reabsorption and urinary concentration, renal ion
transport is essential for renal cell volume adjustment, intracellular
pH regulation, and acidification of intracellular vesicles. Finally,
www.landesbioscience.com Organogenesis 43
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Figure 1. Development of the metanephros. This figure highlights the major
steps in nephrogenesis starting with the formation, growth and branching of
the ureteric bud from the Wolffian duct elicited by inductive signals from the
metanephric blastema (A). In turn, signals originating from the tip of the
ureter induce the metanephric mesenchyme to condense and undergo
nephrogenesis (B). Finally, metanephric development proceeds through a
complex series of morphogenic events including comma- and S-shaped body
structures to give rise to the nephron and its specific components (C).
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passive paracellular pathways, driven by electrochemical gradients,
are required for renal handling of divalent ions such as magnesium
and calcium. This ion transport route is governed by claudins, a
family of tight junction proteins that enable ion specific reabsorp-
tion.18,19 Mutations affecting the function of proteins involved in
transcellular or paracellular transport are the cause of electrolyte
disorders, proteinuria and tubular acidosis.
THE KIDNEY ATLAS PROJECT
The aim of the kidney atlas is to provide a unified graphical envi-
ronment in which to visualize, query, and explore data generated
from a variety of experimental approaches in renal development and
(patho)physiology. It will enable an integrated access to gene function
information whereby diverse data can be explored as part of a global
view of mechanisms and concepts in nephrology. Such an atlas pres-
ents a novel systems approach for studying developmental and disease
processes in an intact organ that may provide a new paradigm in
functional genome research. In the following, we will discuss the
conceptual framework of the organ atlas in detail and we will high-
light the major scientific projects in renal development and disease
that will be incorporated in this atlas.
The core of the atlas will be a series of three-dimen-
sional (3D) reconstructions of the whole kidney. Initially,
we will reconstruct mouse kidneys at embryonic day E17.5
and at 12 weeks of age, prototypes for the embryonic and
the adult organs, respectively. 3D models of the kidney
have greatly facilitated studies of development and disease,
and confocal microscopy and magnetic resonance imaging
technologies have played an important part in studying
the kidney structure. However, both techniques have their
limitations and are not ideal for structures the size of the
mouse kidney. Of several alternative techniques applicable
to this size range, the most promising is optical projection
tomography (OPT) invented by James Sharpe.20,21 OPT
produces 3D images of structures several hundred
micrometers to 1.5 cm in size with a resolution of 10 µm
—without the need to cut sections, a requirement for
other techniques such as confocal microscopy (Fig. 3). An
overriding advantage of OPT is that it captures images of
specimens stained by conventional methods for in situ
hybridization (ISH) and immunohistochemistry. Resulting
images can be studied as 3D objects or as digital sections
(Fig. 3). With respect to the kidney atlas, our initial task
is to adapt OPT technology to renal specimens and to
describe the tissue architecture and molecular anatomy of
the normal developing and adult mouse kidney at two
levels of resolution. Low-resolution, (approx 10 µm)
models will be built from OPT scans of kidneys stained
with antibodies and fluorescent reporters that mark
nephrons, the vasculature and branching collecting system.
High-resolution models will be reconstructed from serial
plastic sections (approx. 3 µm).
In pilot experiments, we have developed protocols that
enabled us to visualize several renal structures in 3D using
OPT of the adult mouse kidney. For detection of
glomeruli, we have taken advantage of a transgenic mouse
line expressing β-galactosidase in all glomerular
podocytes.22 LacZ staining of the glomeruli can be readi-
ly detected using OPT and used to depict the total number
of glomeruli present in the adult organ (Fig. 4A). As an alternative
method, we infused mouse kidneys with beads that attach to
glomeruli and also enabled us to visualize this nephron segment
(Fig. 4B). For detection of the vasculature, we can infuse kidneys
with molten latex and use OPT to reconstruct the entire renal vessel
tree (Fig. 4C).
THE DATABASES
In the kidney atlas, 3D reconstructions of the mouse kidney will
be integrated with a database system that holds data from across the
EuReGene project. These scientific data will be mapped onto the
organ model in such a way that specific data can be related to a distinct
position and developmental time point within the kidney where and
when these data are relevant. The kinds of data represented in the
atlas project range from ISH patterns, to global gene expression
profiles, to description of mutant phenotypes. Most of the information
relates to the mouse kidney, but the atlas will also represent the
evolutionary dimension by including models and data from Xenopus.
These projects cover topics in three important areas of current
research activities in nephrology, namely renal development, renal
pathophysiology, and complex genetics of renal diseases. To ascertain
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Figure 2. Structural and functional organization of the adult nephron. The nephron is
organized in distinct structural elements (left panel) that are characterized by unique
specialized cell types (middle panel), each of which performs specific tasks in volume
and electrolyte homeostasis (right panel). For reasons of simplification, described activities
of renal cell types focus on water and sodium chloride handling along the nephron
segments, an activity that is central to the regulation of body volume and electrolyte
balance, and to blood pressure regulation. (Figure adapted from, The Urinary System.
In: Junqueira LC, Carneiro J, Kelley RO. Eds. Basic Histology. 8th edition. Connecticut:
Appleton & Lange,1995:369).
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comparability of data across all projects, the consortium will use
common standards for experimental procedures such as a unified
ontology for annotation of renal structures, and compliance to
MIAME standards (http://www.mged.org/Workgroups/MIAME/
miame.html) for gene expression profiling. Concerning the laboratory
animals, wherever possible studies will be performed in male mice of
the C57BL/6 strain at E17.5 for the embryonic and 12 weeks of age
for the adult stage.
In renal development (Table 1A). Major efforts will be directed
at elucidating the basis of congenital renal and urogenital tract
anomalies as a major cause of morbidity and mortality in children.
Uncovering the developmental programming of the kidney is crucial
to understanding the resulting diseases as well as the repair processes
whereby the kidney responds to insults (as in diabetes and hyperten-
sion). Ultimately, this may lead to strategies in stem cell technology
for renal replacement therapy. Important questions in this respect
include what is the inductive signal from the ureteric tip that
induces nephrogenesis, what drives nephron patterning, and how is
vasculogenesis during kidney development regulated?
In renal pathophysiology (Table 1B). Our studies aim at under-
standing the genetic origins of volume, electrolyte and blood pressure
disorders caused by abnormalities in renal cell physiology. Chief
among recent advances in this field are the identification of key
genes in renal development (e.g., transcription factors, signaling
molecules), renal structure (e.g., podocyte proteins) and renal func-
tion (e.g., transporters, ion channels, endocytic receptors). However,
presently we know little about the regulatory pathways in which
they act. Thus, we aim at developing new mouse and rat models of
renal pathophysiology for defining disease processes through compar-
ative genomic analysis. We will apply improved cell (tubular,
endothelial, glomerular, interstitial) and organ systems, and
functional genomic tools (transcriptome analysis, imaging
techniques) to define regulatory maps of cell growth and
differentiation, homeostasis and cell-cell interaction.
Construction of regulatory maps will be imperative to
understand disease processes, and, more importantly, it will
identify future targets for therapeutic intervention.
In complex genetics (Table 1C). We focus on the identifi-
cation of modifiers and susceptibility factors that contribute
to complex traits underlying the majority of human renal
diseases (e.g., diabetic nephropathy, proteinuria, glomeru-
losclerosis). To do so, we will explore established animal
models of complex renal diseases to characterize modifiers in
expression and in linkage studies, and we will apply the
results of large-scale ENU screens to identify novel mouse
models of renal disorders.
The European Renal Genome Project
Figure 4. Three-dimensional reconstruction of glomeruli and vasculature in adult
mouse kidneys. (A and B) OPT was used to reconstruct the 3D architecture of the
glomeruli in the adult mouse kidney using lacZ staining in mice expressing the β-galac-
tosidase gene in podocytes (A) or infusion of beads that are trapped in the glomeruli
of normal mice (B). (C) OPT reconstruction of the vascular tree in the adult mouse
kidney infused with molten latex. (Pictures courtesy of Jane Armstrong, University of
Edinburgh and Annemieke IJpenberg, MRC, Edinburgh).
Figure 3. Optical projection tomography. Optical projection tomography
(OPT) has been developed for 3D reconstruction of whole mount in situ or
immunohistological analysis of early mouse embryos. (A). An E11.5 mouse
embryo whole-mount stained for expression of the Sox9 gene (in which the
staining is clearly visible, but determining exactly which tissues are express-
ing is not possible). (B) A 50-µm thick vibratome section cut through a simi-
lar whole-mount stained embryo, in which expression can be seen in sever-
al tissues. (C) The 3D OPT reconstruction of the embryo shown in (A). Virtual
sections in three orthogonal planes are shown, within the context of the full
3D block of voxel data.
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PERSPECTIVE
By the end of the EuReGene project period (2005–2008), the
full kidney atlas will be made available as a public resource. The atlas
will provide an intuitively easy way to browse and explore diverse
data (Fig. 5). Users will be able to browse the data spatially, moving
the mouse cursor across images of kidney sections and pulling up the
different kinds of data that relate to each position. They will be able
to query data textually, where this has been annotated. A query
interface will enable users to ask where, and when during development,
particular genes are expressed or to ask which genes are expressed in
particular locations. To the extent that data have been spatially
mapped to the models, it will be possible to use, for example, the
coexpression domain of two genes to ask which other genes are
expressed in this region, or enable us to link ISH data to micro array
expression data not only by gene name but by consistent textual and
spatial annotations of in situ patterns and the origin of micro array
samples. In another example, we plan to link data on mutant kidney
phenotypes to gene expression patterns by cross-referencing through
gene name and the anatomy or spatial localization of the affected
parts. Initially, the data bases incorporated in the kidney atlas will
mainly consist of data produced within the consortium (Table 1).
Eventually, other genome resources can be included through a com-
mon bioinformatics interface forming the basis for a large integrative
resource for genome research into the genetics of kidney development
and disease.
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Table 1 Overview of scientific projects in three areas of kidney research that will be implemented in the kidney atlas
Area of research Project Approach 
A. Renal Development 
Systematic approaches Renal expression maps of major gene families (solute Automated high throughput ISH on embryonic and 
carriers, G-protein coupled receptors, transcription factors) adult mouse kidney sections, and Xenopus embryos
Global renal gene expression profiling Oligonucleotide micro arrays on E9.0, E10.5, E12.5, 
E14.5 and E17.5, and adult mouse kidneys 
Monogenic approaches Ureter induction, growth and branching Developmental studies in Wt1-, Wnt11-, Sox8, Sox9, 
vHNF1-deficient mice 
Inductive signals in nephrogenesis provided by Wnt4 Studies on inductive signals in nephrogenesis
Patterning and terminal differentiation Studies on differentiation of renal cell types by siRNA
knockdown approaches in cell lines and organ cultures as 
well as morpholino knockdowns in Xenopus embryos
B. Renal (Patho)physiology
Monogenic approaches Ion transport Mouse models with defects in claudins, chloride channels
in renal physiology and sodium transporters 
Acid-base and phosphate transport Mouse models of functional deficiency for NaPi-IIa and
accessory factors 
Protein transport Mouse models of endocytosis defects in proximal tubules
(megalin, cubilin, ClC-5, Dab2) 
Monogenic approaches Glomerulosclerosis Studies in Wt1- and podocin-deficient mice, and in animals
in renal pathology with induced glomerular expression of Pax2 
Inflammation Mouse and rat models of hypertension-induced renal damage
and vasculitis 
Nephrotoxicity Studies on nephrotoxicity induced by drugs in rat and mouse
models 
C. Complex Genetics 
Mapping of modifier genes Proteinuric kidney damage Mapping studies in Munich Wistar Fromter rat model of
in established renal disease proteinuria 
models
Diabetic nephropathy Mapping studies in ENU mouse models of types 2 diabetes
Renal stone disease Mapping studies in ENU mouse models of hypercalciuric
kidney stone disease 
Glomerulosclerosis Mapping in mouse model of focal segmental glomerulosclerosis 
Mapping of new disease Volume and electrolyte disorders Screen for volume and electrolyte anomalies in ENU mice
genes
Details of these projects can be found at www.euregene.org.
 
